Decreased levels of the transmembrane protein claudin-1 (CLDN1), a major component of TJs, are strongly associated with atopic dermatitis, leading to barrier function impairment and increased inflammation [2,8]. This evidence concerns the gene CLDN1 and atopic eczema.